LAMICTAL (lamotrigine) Tablets
... PRECAUTIONS: Drug Interactions). Most clinical experience is derived from patients taking these AEDs. Estrogen-containing oral contraceptives and rifampin have also been shown to increase the apparent clearance of lamotrigine (see PRECAUTIONS: Drug Interactions). Valproate decreases the apparent cle ...
... PRECAUTIONS: Drug Interactions). Most clinical experience is derived from patients taking these AEDs. Estrogen-containing oral contraceptives and rifampin have also been shown to increase the apparent clearance of lamotrigine (see PRECAUTIONS: Drug Interactions). Valproate decreases the apparent cle ...
DELIRIUM IN CRITICAL CARE ANAESTHESIA TUTORIAL OF THE WEEK 232 18
... hepatically metabolised with an elimination half-life of 10-36 hours secondary to active metabolites. Recognised adverse side effects include extra-pyramidal side effects, prolonged QT interval (which can precipitate torsades de point) and neuroleptic malignant syndrome. The optimum dosing schedule ...
... hepatically metabolised with an elimination half-life of 10-36 hours secondary to active metabolites. Recognised adverse side effects include extra-pyramidal side effects, prolonged QT interval (which can precipitate torsades de point) and neuroleptic malignant syndrome. The optimum dosing schedule ...
Migraine Variants and Beyond
... a channelopathy. There are 3 known loci for FHM. FHM1, which accounts for approximately 50% of FHM patients, is caused by mutations in a gene coding for the P/Q-type calcium channel subunit, CACNA1A. FHM1 is also associated with cerebellar degeneration. FHM2, which accounts for <25% of FHM cases, is ...
... a channelopathy. There are 3 known loci for FHM. FHM1, which accounts for approximately 50% of FHM patients, is caused by mutations in a gene coding for the P/Q-type calcium channel subunit, CACNA1A. FHM1 is also associated with cerebellar degeneration. FHM2, which accounts for <25% of FHM cases, is ...
Docetaxel Prescribing Information
... All patients should be premedicated with oral corticosteroids (see below for prostate cancer) such as dexamethasone 16 mg per day (e.g., 8 mg twice daily) for 3 days starting 1 day prior to docetaxel administration in order to reduce the incidence and severity of fluid retention as well as the sever ...
... All patients should be premedicated with oral corticosteroids (see below for prostate cancer) such as dexamethasone 16 mg per day (e.g., 8 mg twice daily) for 3 days starting 1 day prior to docetaxel administration in order to reduce the incidence and severity of fluid retention as well as the sever ...
Scleroderma Understanding and Managing
... range from very mild to life-threatening. The seriousness will depend on what parts of the body are affected and the extent to which they are affected. A mild case can become more serious if not properly treated. Prompt and proper diagnosis and treatment by qualified physicians may minimize the sym ...
... range from very mild to life-threatening. The seriousness will depend on what parts of the body are affected and the extent to which they are affected. A mild case can become more serious if not properly treated. Prompt and proper diagnosis and treatment by qualified physicians may minimize the sym ...
Number II Pemphigus vulgaris
... groups such as Ashkenazi Jews and those of Mediterranean and Indian origin, are especially liable.Oral lesions are initially vesiculobullous but readily rupture, new bullae developing as the older ones rupture and ulcerate. Biopsy of perilesional tissue, with histological and immunostaining examinat ...
... groups such as Ashkenazi Jews and those of Mediterranean and Indian origin, are especially liable.Oral lesions are initially vesiculobullous but readily rupture, new bullae developing as the older ones rupture and ulcerate. Biopsy of perilesional tissue, with histological and immunostaining examinat ...
Review Experimental, Controversial, and Futuristic Treatments for
... 2. A different type of acoustic therapy was described by Reavis et al (2012), who presented a variety of amplitude- and frequency-modulated tones for 3 min at a time to 20 patients with chronic tinnitus. These sounds, in addition to white noise, were presented in a random order to all subjects and a ...
... 2. A different type of acoustic therapy was described by Reavis et al (2012), who presented a variety of amplitude- and frequency-modulated tones for 3 min at a time to 20 patients with chronic tinnitus. These sounds, in addition to white noise, were presented in a random order to all subjects and a ...
Croup Clinical Care Guideline - Children`s Hospital Colorado
... from tracheitis (laryngotrachealbronchitis or –pneumonitis), a more extensive process 3. Single dose corticosteroids 4. Nebulized epinephrine 5. Careful clinical monitoring 6. Passive smoke avoidance Not routinely Indicated: 1. Antibiotics 2. Viral testing 3. Radiographs (chest xray [CXR] and/or lat ...
... from tracheitis (laryngotrachealbronchitis or –pneumonitis), a more extensive process 3. Single dose corticosteroids 4. Nebulized epinephrine 5. Careful clinical monitoring 6. Passive smoke avoidance Not routinely Indicated: 1. Antibiotics 2. Viral testing 3. Radiographs (chest xray [CXR] and/or lat ...
DOI: 10.1542/peds.2010-1308 published online Jul 26, 2010
... of modern insecticides, various botanical treatments, inorganic poisons, and petroleum products were used to treat head lice infestation.1 Shaving heads was also quite effective. The development of dichlorodiphenyltrichloroethane (DDT) after World War II offered a significant advancement in treatment ...
... of modern insecticides, various botanical treatments, inorganic poisons, and petroleum products were used to treat head lice infestation.1 Shaving heads was also quite effective. The development of dichlorodiphenyltrichloroethane (DDT) after World War II offered a significant advancement in treatment ...
BUPRENORPHINE RESOURCE GUIDE
... At least one prescribing physician needs to be waivered to provide buprenorphine (though it is good for more than one to be waivered for back-up). Only physicians can prescribe buprenorphine. Before a physician may prescribe buprenorphine, he or she must meet eligibility by being trained and then ap ...
... At least one prescribing physician needs to be waivered to provide buprenorphine (though it is good for more than one to be waivered for back-up). Only physicians can prescribe buprenorphine. Before a physician may prescribe buprenorphine, he or she must meet eligibility by being trained and then ap ...
the PDF - Heart Rhythm Society
... Guidelines and Expert Consensus documents aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decisionmaking. A great number of Guid ...
... Guidelines and Expert Consensus documents aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decisionmaking. A great number of Guid ...
the mechanism of acupuncture and clinical applications
... the secretion of endorphin, which plays a role in producing the analgesic effect of hypophysis (Takeshige et al., 1992). It also plays a role in the increase of the endorphin level in plasma and the central nervous system (Jin et al., 1996; Fu, 2000). It has been observed that secretion of beta endo ...
... the secretion of endorphin, which plays a role in producing the analgesic effect of hypophysis (Takeshige et al., 1992). It also plays a role in the increase of the endorphin level in plasma and the central nervous system (Jin et al., 1996; Fu, 2000). It has been observed that secretion of beta endo ...
Company presentation
... Macitentan hemodynamic sub-study Macitentan in patients with and w/o anticoagulant Macitentan in patients with and w/o RV function ...
... Macitentan hemodynamic sub-study Macitentan in patients with and w/o anticoagulant Macitentan in patients with and w/o RV function ...
Prevention and Treatment of Cancer-Related Infections
... d See Antibacterial Agents (FEV-A) for dosing, spectrum, and specific comments/cautions. e See Antifungal Agents (FEV-B) for dosing, spectrum, and specific comments/cautions. f See Antiviral Agents (FEV-C) for dosing, spectrum, and specific comments/cautions. g Although data support levofloxacin pro ...
... d See Antibacterial Agents (FEV-A) for dosing, spectrum, and specific comments/cautions. e See Antifungal Agents (FEV-B) for dosing, spectrum, and specific comments/cautions. f See Antiviral Agents (FEV-C) for dosing, spectrum, and specific comments/cautions. g Although data support levofloxacin pro ...
Prevention and Treatment of Cancer-Related Infections
... d See Antibacterial Agents (FEV-A) for dosing, spectrum, and specific comments/cautions. e See Antifungal Agents (FEV-B) for dosing, spectrum, and specific comments/cautions. f See Antiviral Agents (FEV-C) for dosing, spectrum, and specific comments/cautions. g Although data support levofloxacin pro ...
... d See Antibacterial Agents (FEV-A) for dosing, spectrum, and specific comments/cautions. e See Antifungal Agents (FEV-B) for dosing, spectrum, and specific comments/cautions. f See Antiviral Agents (FEV-C) for dosing, spectrum, and specific comments/cautions. g Although data support levofloxacin pro ...
formulary information
... subjects aged 65 and over to determine whether they had a different clinical response than younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dosing in elderly patients should be cautious, reflecting ...
... subjects aged 65 and over to determine whether they had a different clinical response than younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dosing in elderly patients should be cautious, reflecting ...
Lamotrigin Medochemie tablet ENG
... events cannot be excluded. Therefore, consideration should be given to using contraception without a pill-free week, as first-line therapy (for example, continuous hormonal contraceptives or non-hormonal methods; see sections 4.4 and 4.5). Starting hormonal contraceptives in patients already taking ...
... events cannot be excluded. Therefore, consideration should be given to using contraception without a pill-free week, as first-line therapy (for example, continuous hormonal contraceptives or non-hormonal methods; see sections 4.4 and 4.5). Starting hormonal contraceptives in patients already taking ...
The Interface Formulary For Adults
... The content of the formulary reflects nationally recognised evidence or consensus opinion at the time of compilation. Evidence or opinion may change over time and it is the responsibility of the prescriber to ensure that new evidence or national guidelines are taken into account in their prescribing ...
... The content of the formulary reflects nationally recognised evidence or consensus opinion at the time of compilation. Evidence or opinion may change over time and it is the responsibility of the prescriber to ensure that new evidence or national guidelines are taken into account in their prescribing ...
PRODUCT MONOGRAPH PREVACID PREVACID FasTab
... Safety concerns of long-term treatment relate to hypergastrinemia, possible enterochromaffinlike (ECL) effect and carcinoid formation. ECL cell hyperplasia and gastric carcinoid tumours were observed in four animal studies. In two 24-month carcinogenicity studies, Sprague-Dawley rats were treated or ...
... Safety concerns of long-term treatment relate to hypergastrinemia, possible enterochromaffinlike (ECL) effect and carcinoid formation. ECL cell hyperplasia and gastric carcinoid tumours were observed in four animal studies. In two 24-month carcinogenicity studies, Sprague-Dawley rats were treated or ...
Global Initiative for Chronic Obstructive Lung D isease
... burden and create treatment plans. A summary of publications that have examined the ABCD grading system since its first presentation in 2011 is provided in the table on the next page. Additional evidence generated from using the original and the revised system proposed in this 2017 GOLD Report will ...
... burden and create treatment plans. A summary of publications that have examined the ABCD grading system since its first presentation in 2011 is provided in the table on the next page. Additional evidence generated from using the original and the revised system proposed in this 2017 GOLD Report will ...
Increased Caffeine Consumption Is Associated
... Although coffee consumption has been associated with reduced frequency of liver disease, it is unclear whether the effect is from coffee or caffeine and whether there is an effect on hepatic fibrosis specifically. This study was undertaken to use a food-frequency instrument for dietary caffeine consum ...
... Although coffee consumption has been associated with reduced frequency of liver disease, it is unclear whether the effect is from coffee or caffeine and whether there is an effect on hepatic fibrosis specifically. This study was undertaken to use a food-frequency instrument for dietary caffeine consum ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
... weeks (Day 57) of therapy. Aminosalicylates and/or corticosteroids may be continued during treatment with HUMIRA. Azathioprine and 6-mercaptopurine (6-MP) [see Warnings and Precautions (5.2)] may be continued during treatment with HUMIRA if necessary. 2.5 Plaque Psoriasis The recommended dose of HUM ...
... weeks (Day 57) of therapy. Aminosalicylates and/or corticosteroids may be continued during treatment with HUMIRA. Azathioprine and 6-mercaptopurine (6-MP) [see Warnings and Precautions (5.2)] may be continued during treatment with HUMIRA if necessary. 2.5 Plaque Psoriasis The recommended dose of HUM ...
Peritoneal Dialysis
... recommends PD as the initial dialysis treatment of choice of chronic kidney disease stage 5 for children aged 2 years or older, people with residual renal function and adults without significant associated comorbidities. ...
... recommends PD as the initial dialysis treatment of choice of chronic kidney disease stage 5 for children aged 2 years or older, people with residual renal function and adults without significant associated comorbidities. ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.